asia healthspace

Supply drivers and trends in Asia   Strong demand inadequately met by current infrastructure At 2.08 beds and 1.09 doctors per 1,000 population, Asia and Australasia lags behind the global average (2.72 and 1.72 respectively, refer to Figure 6 below).[i] As Asia continues in its growth trajectory, demand will continue to outstrip supply. The market [...]

Demand drivers and trends in Asia GDP growth drives healthcare spending   With real GDP growth rates almost double the global average (5.70% compared to 2.30%[i]), Asia will be a prime driver of global economic growth going forward. At real GDP growth in the range of 5–8% in Asia annually, and with healthcare projected to [...]

The following series of posts describing the current landscape in the Hospital sector in prominent Asia Pacific markets are derived from a proprietary report developed by Clearstate. Clearstate, an Economist Intelligence Unit healthcare business, is the market leader in healthcare research-based consulting in the emerging markets. The analysis and content in this report is derived [...]

A highly heterogeneous region, Asia has established itself as one of the most exciting and challenging markets across many industries, but particularly so for healthcare products and services. Beyond price affordability issues, logistical challenges, and the regulatory labyrinths, many parts of Asia are also plagued by cultural barriers, especially for women’s health management. The lack [...]

In this post I provide for your benefit a snapshot summary of the on-going healthcare reforms being undertaken in China courtesy of a report from Ernst and Young titled “Progressions Pharma 3.0; A Global Pharmaceutical report 2010″ as well as a smart article by Wharton Business School published on March 30, 2011, on the Knowledge [...]

This insightful article was provided to us by one of our contributors James J. Gillespie, President, Center for Healthcare Innovation and Brian Speicher, MBA Candidate, Sloan School of Management, MIT. “To a great extent, we have lost control of the data and, in many ways, our traditional position as information providers. Patients and others now [...]

In life, people traditionally value symmetry; symmetry of our appearance (anyone’s three wishes in life include infliction with Bell’s palsy? I think not!); symmetry of arts and architecture; and, of course, symmetry of interaction (Do unto others as you would have others do unto you). However, over the course of my professional career both in [...]

Over the past three years I have had the good fortune of working closely with Adam Barak who is the Head of International Pricing and Reimbursement at United BioSource Corporation. UBC is a leader in peri- and post-approval product development; safety and risk management; health economics and outcomes research; pricing, coverage, reimbursement, and access strategies; [...]

Those who know me well, know that I have a passion for economics and finance and without fail, I compliantly take my daily dose (nice medical metaphor!) of financial news and bloggers. One of the financial blogs I follow and mostly respect, is called “Naked Capitalism” which is founded and managed by Yves Smith. Well [...]

A seemingly ubiquitous item on the reform agenda of most developed and now developing nations is “healthcare reform”. Whether we talk about the U.S. private/hybrid health care system or universal healthcare systems such as Canada’s, U.K.’s, Australia’s, and France’s, it appears the grass is much greener on the other side though as far as I [...]